88 related articles for article (PubMed ID: 2263741)
1. Detection of African horsesickness (AHS) in recently vaccinated horses with inactivated vaccine in Qatar.
Hassanain MM; al-Afaleq AI; Soliman IM; Abdullah SK
Rev Elev Med Vet Pays Trop; 1990; 43(1):33-5. PubMed ID: 2263741
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the pathogenicity of African Horsesickness (AHS) isolates in vaccinated animals.
von Teichman BF; Smit TK
Vaccine; 2008 Sep; 26(39):5014-21. PubMed ID: 18682269
[TBL] [Abstract][Full Text] [Related]
3. In vivo cross-protection to African horse sickness Serotypes 5 and 9 after vaccination with Serotypes 8 and 6.
von Teichman BF; Dungu B; Smit TK
Vaccine; 2010 Sep; 28(39):6505-17. PubMed ID: 20638456
[TBL] [Abstract][Full Text] [Related]
4. Recommendations for African horse sickness vaccines for use in nonendemic areas.
House JA
Rev Elev Med Vet Pays Trop; 1993; 46(1-2):77-81. PubMed ID: 8134660
[TBL] [Abstract][Full Text] [Related]
5. Characterization of virulence variants of African horsesickness virus.
Laegreid WW; Skowronek A; Stone-Marschat M; Burrage T
Virology; 1993 Aug; 195(2):836-9. PubMed ID: 8337849
[TBL] [Abstract][Full Text] [Related]
6. Control and eradication of African horse sickness with vaccine.
Sánchez-Vizcaíno JM
Dev Biol (Basel); 2004; 119():255-8. PubMed ID: 15742636
[TBL] [Abstract][Full Text] [Related]
7. [Use of the immunoenzyme test ELISA-NS3 to distinguish horses infected by African horsesickness virus from vaccinated horses].
Idrissi Bougrine S; Fassi Fihri O; el Harrak M; Fassi Fehri MM
Rev Sci Tech; 1999 Dec; 18(3):618-26. PubMed ID: 10588005
[TBL] [Abstract][Full Text] [Related]
8. Inactivated and adjuvanted vaccine for the control of the African horse sickness virus serotype 9 infection: evaluation of efficacy in horses and guinea-pig model.
Lelli R; Molini U; Ronchi GF; Rossi E; Franchi P; Ulisse S; Armillotta G; Capista S; Khaiseb S; Di Ventura M; Pini A
Vet Ital; 2013; 49(1):89-98. PubMed ID: 23564590
[TBL] [Abstract][Full Text] [Related]
9. African horse-sickness killed-virus tissue culture vaccine.
Ozawa Y; Bahrami S
Can J Comp Med Vet Sci; 1966 Nov; 30(11):311-4. PubMed ID: 4226381
[TBL] [Abstract][Full Text] [Related]
10. Further studies on the efficacy of an inactivated African horse sickness serotype 4 vaccine.
House JA; Lombard M; Dubourget P; House C; Mebus CA
Vaccine; 1994 Feb; 12(2):142-4. PubMed ID: 8147096
[TBL] [Abstract][Full Text] [Related]
11. Humoral antibody response of 10 horses after vaccination against African horse sickness with an inactivated vaccine containing all 9 serotypes in one injection.
Wernery U; Rodriguez M; Raghavan R; Syriac G; Miriam Thomas M S; Elizabeth SK; Federico Ronchi G; Muhammed R; Patteril NA; Joseph S
Equine Vet J; 2021 Jul; 53(4):826-833. PubMed ID: 33011979
[TBL] [Abstract][Full Text] [Related]
12. Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus.
Guthrie AJ; Quan M; Lourens CW; Audonnet JC; Minke JM; Yao J; He L; Nordgren R; Gardner IA; Maclachlan NJ
Vaccine; 2009 Jul; 27(33):4434-8. PubMed ID: 19490959
[TBL] [Abstract][Full Text] [Related]
13. Preliminary findings for an inactivated African horsesickness vaccine using binary ethyleneimine.
Hassanain MM
Rev Elev Med Vet Pays Trop; 1992; 45(3-4):231-4. PubMed ID: 1339986
[TBL] [Abstract][Full Text] [Related]
14. Investigations on outbreaks of African horse sickness in the surveillance zone in South Africa.
Venter GJ; Koekemoer JJ; Paweska JT
Rev Sci Tech; 2006 Dec; 25(3):1097-109. PubMed ID: 17361773
[TBL] [Abstract][Full Text] [Related]
15. Immunization with VP2 is sufficient for protection against lethal challenge with African horsesickness virus Type 4.
Stone-Marschat MA; Moss SR; Burrage TG; Barber ML; Roy P; Laegreid WW
Virology; 1996 Jun; 220(1):219-22. PubMed ID: 8659117
[TBL] [Abstract][Full Text] [Related]
16. Preparation of recombinant African horse sickness virus VP7 antigen via a simple method and validation of a VP7-based indirect ELISA for the detection of group-specific IgG antibodies in horse sera.
Maree S; Paweska JT
J Virol Methods; 2005 Apr; 125(1):55-65. PubMed ID: 15737417
[TBL] [Abstract][Full Text] [Related]
17. Comparative immune responses after vaccination with the formulated inactivated African horse sickness vaccine serotype 1 between naïve horses and pretreated horses with the live-attenuated African horse sickness vaccine.
Chaiyabutr N; Wattanaphansak S; Tantilerdcharoen R; Akesowan S; Ouisuwan S; Naraporn D
Vet World; 2022 Oct; 15(10):2365-2375. PubMed ID: 36425136
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of different African horsesickness virus serotypes in the Onderstepoort area near Pretoria, during an outbreak of African horsesickness in South Africa in 1995/1996.
Bremer CW; Gerdes GH; Aitchison H; Louw I; Greyling RR; Welgemoed J
Onderstepoort J Vet Res; 2000 Mar; 67(1):65-70. PubMed ID: 10843324
[TBL] [Abstract][Full Text] [Related]
19. African horsesickness virus serotyping and identification of multiple co-infecting serotypes with a single genome segment 2 RT-PCR amplification and reverse line blot hybridization.
Koekemoer JJ; Dijk AA
J Virol Methods; 2004 Dec; 122(1):49-56. PubMed ID: 15488620
[TBL] [Abstract][Full Text] [Related]
20. Investigation of antigen specific lymphocyte responses in healthy horses vaccinated with an inactivated West Nile virus vaccine.
Davis EG; Zhang Y; Tuttle J; Hankins K; Wilkerson M
Vet Immunol Immunopathol; 2008 Dec; 126(3-4):293-301. PubMed ID: 18838173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]